Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis

Journal of Clinical Investigation

Volumn 116, Issue 2, 2006, Pages 456-464

  Prinz, Marco ^a   Garbe, Folker ^a   Schmidt, Hauke ^a   Mildner, Alexander ^a   Gutcher, Ilona ^b   Wolter, Karina ^a   Piesche, Matthias ^a   Schroers, Roland ^a   Weiss, Elisabeth ^a   Kirschning, Carsten J ^c   Rochford, Christian D P ^d   Brück, Wolfgang ^a   Becher, Burkhard ^a,b  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d EUROPEAN NEUROSCIENCE INSTITUTE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MYELOID DIFFERENTIATION FACTOR 88; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TOLL LIKE RECEPTOR 9;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; BRAIN NERVE CELL; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CPG ISLAND; DISEASE COURSE; FEMALE; GENE MUTATION; HISTOPATHOLOGY; HOST CELL; HOST RESISTANCE; HUMAN; HUMAN CELL; INNATE IMMUNITY; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; RADIOSENSITIVITY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADOPTIVE TRANSFER; ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; GENOTYPE; IMMUNITY, NATURAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELOID DIFFERENTIATION FACTOR 88; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 9; TRANSPLANTATION CHIMERA;

EID: 32444443739     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI26078     Document Type: Article

References (43)

1. Steinman, L. 1996. Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system. Cell. 85:299-302.
2. Owens, T., Wekerle, H., and Antel, J. 2001. Genetic models for CNS inflammation. Nat. Med. 7:161-166.
3. Banchereau, J., and Steinman, R.M. 1998. Dendritic cells and the control of immunity. Nature. 392:245-252.
4. Schnare, M., et al. 2001. Toll-like receptors control activation of adaptive immune responses. Nat. Immunol. 2:947-950.
5. Takeda, K., and Akira, S. 2005. Toll-like receptors in innate immunity. Int. Immunol. 17:1-14.
6. Beutler, B. 2004. Inferences, questions and possibilities in Toll-like receptor signalling. Nature. 430:257-263.
7. Matzinger, P. 1994. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12:991-1045.
8. Lemaitre, B., Nicolas, E., Michaut, L., Reichhart, J.M., and Hoffmann, J.A. 1996. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell. 86:973-983.
9. Medzhitov, R., et al. 1998. MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Mol. Cell. 2:253-258.
10. Muzio, M., Ni, J., Feng, P., and Dixit, V.M. 1997. IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling. Science. 278:1612-1615.
11. Prinz, M., et al. 2003. Prion pathogenesis in the absence of Toll-like receptor signalling. EMBO Rep. 4:195-199.
12. Adachi, O., et al. 1998. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity. 9:143-150.
13. Kawai, T., Adachi, O., Ogawa, T., Takeda, K., and Akira, S. 1999. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity. 11:115-122.
14. Takeuchi, O., et al. 2000. Cellular responses to bacterial cell wall components are mediated through MyD88dependent signaling cascades. Int. Immunol. 12:113-117.
15. Hemmi, H., et al. 2002. Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat. Immunol. 3:196-200.
16. Hacker, H., et al. 2000. Immune cell activation by bacterial CpG-DNA through myeloid differentiation marker 88 and tumor necrosis factor receptor-associated factor (TRAF)6. J. Exp. Med. 192:595-600.
17. Hayashi, F., et al. 2001. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature. 410:1099-1103.
18. Segal, B.M., Chang, J.T., and Shevach, E.M. 2000. CpG oligonucleotides are potent adjuvants for the activation of autoreactive encephalitogenic T cells in vivo. J. Immunol. 164:5683-5688.
19. Olson, J.K., and Miller, S.D. 2004. Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J. Immunol. 173:3916-3924.
20. Lehnardt, S., et al. 2003. Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway. Proc. Natl. Acad. Sci. U. S. A. 100:8514-8519.
21. Bsibsi, M., Ravid, R., Gveric, D., and van Noort, J.M. 2002. Broad expression of Toll-like receptors in the human central nervous system. J. Neuropathol. Exp. Neurol. 61:1013-1021.
22. Pasare, C., and Medzhitov, R. 2004. Toll-dependent control mechanisms of CD4 T cell activation. Immunity. 21:733-741.
23. Becher, B., Durell, B.G., Miga, A.V., Hickey, W.F., and Noelle, R.J. 2001. The clinical course of experimental autoimmune encephalomyelitis and inflammation is controlled by the expression of CD40 within the central nervous system. J. Exp. Med. 193:967-974.
24. Becher, B., Durell, B.G., and Noelle, R.J. 2003. IL-23 produced by CNS-resident cells controls T cell encephalitogenicity during the effector phase of experimental autoimmune encephalomyelitis. J. Clin. Invest. 112:1186-1191. doi:10.1172/JCI200319079.
25. Greter, M., et al. 2005. Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis. Nat. Med. 11:328-334.
26. Prinz, M., et al. 2003. Positioning of follicular dendritic cells within the spleen controls prion neuroinvasion. Nature. 425:957-962.
27. Asheuer, M., et al. 2004. Human CD34+ cells differentiate into microglia and express recombinant therapeutic protein. Proc. Natl. Acad. Sci. U. S. A. 101:3557-3562.
28. Hickey, W.F., Vass, K., and Lassmann, H. 1992. Bone marrow-derived elements in the central nervous system: an immunohistochemical and ultrastructural survey of rat chimeras. J. Neuropathol. Exp. Neurol. 51:246-256.
29. Priller, J., et al. 2001. Targeting gene-modified hematopoietic cells to the central nervous system: use of green fluorescent protein uncovers microglial engraftment. Nat. Med. 7:1356-1361.
30. Compston, A., and Coles, A. 2002. Multiple sclerosis. Lancet. 359:1221-1231.
31. Casetta, I., and Granieri, E. 2000. Prognosis of multiple sclerosis:environmental factors. Neurol. Sci. 21:S839-S842.
32. Buljevac, D., et al. 2002. Prospective study on the relationship between infections and multiple sclerosis exacerbations. Brain. 125:952-960.
33. Oksenberg, J.R., et al. 1993. Selection for T-cell receptor Vβ-Dβ-Jβ gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis. Nature. 362:68-70.
34. Heppner, F.L., et al. 2005. Experimental autoimmune encephalomyelitis repressed by microglial paralysis. Nat. Med. 11:146-152.
35. Quesniaux, V., et al. 2004. Toll-like receptor pathways in the immune responses to mycobacteria. Microbes Infect. 6:946-959.
36. Pasare, C., and Medzhitov, R. 2003. Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science. 299:1033-1036.
37. Hemmi, H., et al. 2000. A Toll-like receptor recognizes bacterial DNA. Nature. 408:740-745.
38. Yasuda, K., et al. 2005. Endosomal translocation of vertebrate DNA activates dendritic cells via TLR9-dependent and -independent pathways. J. Immunol. 174:6129-6136.
39. Bauer, J., et al. 1998. T-cell apoptosis in inflammatory brain lesions. Destruction of T cells does not depend on antigen recognition. Am. J. Pathol. 153:715-724.
40. Leadbetter, E.A., et al. 2002. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature. 416:603-607.
41. Kerfoot, S.M., et al. 2004. TLR4 contributes to disease-inducing mechanisms resulting in central nervous system autoimmune disease. J. Immunol. 173:7070-7077.
42. Werts, C., et al. 2001. Leptospiral lipopolysaccharide activates cells through a TLR2-dependent mechanism. Nat. Immunol. 2:346-352.
43. Koedel, U., et al. 2003. Toll-like receptor 2 participates in mediation of immune response in experimental pneumococcal meningitis. J. Immunol. 170:438-444.